NORWOOD, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (CRBP), a clinical-stage company focused on oncology and obesity, today announced the initiation of the multiple ...
Advancing toward Phase 2a clinical evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track consideration This milestone follows the completion ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果